See also this year's filing and all EDGAR filings for this company.
PDF Report 0001328143_2015_Adamas_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001328143, Adamas Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 123,527,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,228,000 |
| 3 | remainder_Assets | 36,434,000 |
| 4 | LiabilitiesCurrent | 12,545,000 |
| 5 | LiabilitiesNoncurrent | 1,570,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,472,000 |
| 9 | ResearchAndDevelopmentExpense | 21,860,000 |
| 10 | remainder_Expenses | 8,291,000 |
| 11 | remainder_Revenues | 55,846,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -180,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 161,189,000 |
| 1 | Liabilities | 14,115,000 |
| 2 | Expenses | 45,623,000 |
| 3 | Revenues | 55,846,000 |
| 4 | StockholdersEquity | 147,074,000 |
| 5 | NetIncome | 10,223,000 |
| 6 | ComprehensiveNetIncome | 10,133,000 |
| 7 | BaseVar | 138,476,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.77 |
| 9 | EconomicCapitalRatio | 4.22 |
Edgar->Model Mapping
Feature Distribution
